Beneficial effect of prostaglandin I2 on smooth muscle cell proliferation.
Zidek
T
T
Atherosclerosis Research Group (ASF) Vienna, Austria.
Steurer
G
G
Fitscha
P
P
Sinzinger
H
H
D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D001158:Arteries / Q000187:drug effects / Q000473:pathology; D001792:Blood Platelets / Q000502:physiology; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D011464:Epoprostenol / Q000494:pharmacology*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008954:Models, Biological; D009131:Muscle, Smooth, Vascular / Q000166:cytology* / Q000187:drug effects / Q000473:pathology; D011817:Rabbits; D014652:Vascular Diseases / Q000473:pathology
D000324:Adrenocorticotropic Hormone; D011464:Epoprostenol